High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis

References

• World Health Organization. Global tuberculosis report 2017. Geneva: World Health Orgnization; 2017.
   Google Scholar
• Millard J, Ugarte-Gil C, Moore DA. Multidrug resistant tuberculosis. BMJ. 2015;350:h882.
   Google Scholar
• Liu Z, Pan A, Wu B, et al. Feasibility of a new model for early detection of patients with multidrug-resistant tuberculosis in a developed setting of eastern China. TMIH. 2017;22:1328–10.
   Google Scholar
• Caminero JA. Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding. Int J Tuberc Lung Dis. 2010;14:382–390.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366:2161–2170.
   PubMed Web of Science ®Google Scholar
• Sachdeva KS, Raizada N, Gupta RS, et al. The potential impact of up-front drug sensitivity testing on India’s epidemic of multi-drug resistant tuberculosis. PloS One. 2015;10:e0131438.
   Web of Science ®Google Scholar
• Yu W. Guidelines for the Prevention and control of multidrug-resistant tuberculosis. Beijing: Military Science Publishing House; 2012.
   Google Scholar
• Minghui R, Scano F, Sozi C, et al. The global fund in China: success beyond the numbers. Lancet Global Health. 2015;3:e75–e77.
   PubMed Web of Science ®Google Scholar
• Cheng MH. Ministerial meeting agrees plan for tuberculosis control. Lancet. 2009;373:1328.
   Web of Science ®Google Scholar
• Long Q, Qu Y, Lucas H. Drug-resistant tuberculosis control in China: progress and challenges. Infect Dis Poverty. 2016;5:9.
   Web of Science ®Google Scholar
• Wang L, Liu X, Huang F, et al. Engaging hospitals to meet tuberculosis control targets in China: using the Internet as a tool to put policy into practice. Bull World Health Organ. 2010;88:937–942. [ Epub 2010/ 12/03].
   Web of Science ®Google Scholar
• Wang L, Li R, Xu C, et al. The Global Fund in China: multidrug-resistant tuberculosis nationwide programmatic scale-up and challenges to transition to full country ownership. PloS One. 2017;12:e0177536.
   Web of Science ®Google Scholar
• Yang C, Luo T, Shen X, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation. Lancet Infect Dis. 2017;17:275–284. [ Epub 2016/ 12/07].
   PubMed Web of Science ®Google Scholar
• Xuzhou Municipal Statistics Bureau, Survey Office of the National Bureau of Statistics in Xuzhou. 2017. Xuzhou statistical yearbook 2017 [ cited 2018 May 15]. Available from: http://tj.xz.gov.cn/TJJ/sjfb/20171117/004011_61c2ff24-c268-47ff-8f4f-9d9b76f514d6.htm.
   Google Scholar
• Zigong Municipal Statistics Bureau, Survey Office of the National Bureau of Statistics in Zigong. 2017 Zigong Statistical Yearbook 2017. [ cited 2018 May 15]. Available from: http://www.zg.gov.cn/web/stjj/-6/-/articles/8515214.shtml.
   Google Scholar
• Gordis L. Epidemiology. Fifth ed. Philadelphia: Elsevier Saunders; 2014.
   Google Scholar
• Ladefoged K, Rendal T, Skifte T, et al. Risk factors for tuberculosis in Greenland: case-control study. Int J Tuberc Lung Dis. 2011;15:44–49.
   PubMed Web of Science ®Google Scholar
• National Health and Family Planning Commission. Ethical review of biomedical research involving human beings. Beijing: National Health and Family Planning Commission; 2016 cited 2018 Mar 15. Available from http://www.moh.gov.cn/fzs/s3576/201610/84b33b81d8e747eaaf048f68b174f829.shtml
   Google Scholar
• Ding P, Li X, Jia Z, et al. Multidrug-resistant tuberculosis (MDR-TB) disease burden in China: a systematic review and spatio-temporal analysis. BMC Infect Dis. 2017;17:57.
   Web of Science ®Google Scholar
• Duan Q, Chen Z, Chen C, et al. The prevalence of drug-resistant tuberculosis in mainland China: an updated systematic review and meta-analysis. PloS One. 2016;11:e0148041. [ Epub 2016/ 02/10].
   Web of Science ®Google Scholar
• Yang XY, Li YP, Mei YW, et al. Time and spatial distribution of multidrug-resistant tuberculosis among Chinese people, 1981–2006: a systematic review. Int J Infect Dis. 2010;14:e828–e837.
   Web of Science ®Google Scholar
• TB Prevention and Control Center, China CDC. The comprehensive TB control model: baseline survey report. Beijing: China CDC; 2013.
   Google Scholar
• Nathanson E, Nunn P, Uplekar M, et al. MDR tuberculosis–critical steps for prevention and control. N Engl J Med. 2010;363:1050–1058.
   PubMed Web of Science ®Google Scholar
• He G X, van den Hof S, van der Werf MJ, et al. Inappropriate tuberculosis treatment regimens in Chinese tuberculosis hospitals. Clin Infect Dis. 2011;52:e153–e156.
   Web of Science ®Google Scholar
• Migliori GB, Sotgiu G, Gandhi NR, et al. Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis. Eur Respir J. 2013;42:169–179.
   PubMed Web of Science ®Google Scholar
• Pritchard AJ, Hayward AC, Monk PN, et al. Risk factors for drug resistant tuberculosis in Leicestershire–poor adherence to treatment remains an important cause of resistance. Epidemiol Infect. 2003;130:481–483.
   Web of Science ®Google Scholar
• Yang X, Li Y, Wen X, et al. Risk factors for drug resistance in pulmonary tuberculosis inpatients. J Evid Based Med. 2010;3:162–167.
   Google Scholar
• Department of Health, Republic of South Africa. Management of drug-resistant tuberculosis policy guideline. Capetown: Department of Health, Republic of South Africa; 2013.
   Google Scholar
• Ramachandran R, Muniyandi M. Rapid molecular diagnostics for multi-drug resistant tuberculosis in India. Expert Rev Anti Infect Ther. 2018;16:197–204.
   PubMed Web of Science ®Google Scholar
• Eliseev P, Balantcev G, Nikishova E, et al. The impact of a line probe assay based diagnostic algorithm on time to treatment initiation and treatment outcomes for multidrug resistant TB patients in Arkhangelsk Region, Russia. PloS One. 2016;11:e0152761.
   Web of Science ®Google Scholar
• Technical Guidance Group of the Fifth National TB Epidemiological Survey, the Office of the Fifth National TB Epidemiological Survey. The fifth national tuberculosis epidemiological survey in 2010. Chin J Antituberc. 2012;34:485–508.
   Google Scholar